SEC Filing Summary: Molina Healthcare, Inc. (8-K)
Business Context and Reporting Period
This Current Report (Form 8-K) was filed on November 7, 2003, by Molina Healthcare, Inc. The report discloses financial results for the three-month period ended September 30, 2003, specifically addressing net income per diluted share under GAAP and pro forma adjustments.
Key Financial Metrics
- GAAP Net Income per Diluted Share: $0.46 for the quarter ended September 30, 2003.
- Pro Forma Net Income per Diluted Share: $0.44.
- Excluded Tax Benefits: $1.0 million related to a tax credit recovery project (total project benefits for the quarter were $1.2 million, with $1.0 million attributable to prior periods).
- Excluded Expenses: $300,000 in tax consulting fees and $700,000 in one-time stock compensation expense triggered by the initial public offering.
- Tax Rate Applied to Adjustments: 37.5%.
The filing does not provide clear values for total revenue, operating profit, cash flow, margins, debt, or liquidity metrics.
Material Changes and Adjustments
The primary material change disclosed is the reconciliation between GAAP and pro forma earnings. The pro forma figure is lower than the GAAP figure due to the exclusion of specific one-time items:
- Removal of $1.0 million in tax benefits from prior periods recognized in the current quarter.
- Removal of $300,000 in consulting fees and $700,000 in stock compensation costs associated with the IPO.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management outlook, or discussion of future risks and contingencies. The report is strictly a disclosure of past quarter results and the methodology for calculating pro forma earnings.
Investor Verification Checklist
- Verify the full reconciliation of GAAP to pro forma net income per diluted share in Exhibit 99.1.
- Confirm the total revenue and operating expenses for the quarter ended September 30, 2003, as these are not detailed in this 8-K summary.
- Review the specific details of the tax credit recovery project to understand the sustainability of the $1.2 million in benefits.
- Assess the impact of the $700,000 one-time stock compensation expense on future quarters post-IPO.